Merck & Co., Inc. (MRK)
150.32
-2.02
(-1.33%)
USD |
NYSE |
Sep 04, 16:00
150.51
+0.19
(+0.13%)
After-Hours: 17:43
Merck Cash and Short Term Investments (Annual) : 14.69B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.69B |
| December 31, 2024 | 13.76B |
| December 31, 2023 | 7.161B |
| December 31, 2022 | 13.27B |
| December 31, 2021 | 8.096B |
| December 31, 2020 | 8.05B |
| December 31, 2019 | 10.45B |
| December 31, 2018 | 8.864B |
| December 31, 2017 | 8.498B |
| December 31, 2016 | 14.34B |
| December 31, 2015 | 13.43B |
| December 31, 2014 | 15.72B |
| December 31, 2013 | 17.49B |
| December 31, 2012 | 16.14B |
| December 31, 2011 | 14.97B |
| December 31, 2010 | 12.20B |
| December 31, 2009 | 9.604B |
| December 31, 2008 | 5.486B |
| December 31, 2007 | 8.231B |
| December 31, 2006 | 8.713B |
| December 31, 2005 | 15.64B |
| December 31, 2004 | 7.090B |
| December 31, 2003 | 4.173B |
| Date | Value |
|---|---|
| December 31, 2002 | 4.971B |
| December 31, 2001 | 3.287B |
| December 31, 2000 | 4.255B |
| December 31, 1999 | 3.202B |
| December 31, 1998 | 3.356B |
| December 31, 1997 | 2.309B |
| December 31, 1996 | 2.182B |
| December 31, 1995 | 3.350B |
| December 31, 1994 | 2.270B |
| December 31, 1993 | 1.542B |
| December 31, 1992 | 1.094B |
| December 31, 1991 | 1.412B |
| December 31, 1990 | 1.197B |
| December 31, 1989 | 1.144B |
| December 31, 1988 | 1.55B |
| December 31, 1987 | 1.148B |
| December 31, 1986 | 965.80M |
| December 31, 1985 | 842.00M |
| December 31, 1984 | 744.32M |
| December 31, 1983 | 370.74M |
| December 31, 1982 | 313.24M |
| December 31, 1981 | 226.61M |
| December 31, 1980 | 302.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Pfizer Inc. | 13.60B |
| Bristol Myers Squibb Co. | 10.67B |
| Abbott Laboratories | 8.939B |